Digestive System Neoplasms Clinical Trials

A listing of Digestive System Neoplasms medical research trials actively recruiting patient volunteers. Use the filters below to narrow your search results.

Filter By:

 

Arizona

Phoenix Arizona 85054

A clinical trial to evaluate treatments for patients with Inflammatory Bowel Disease (IBD), Primary Sclerosing Cholangitis (PSC), Colorectal Neoplasms or Colorectal Cancer

Phoenix Arizona 85054

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Scottsdale Arizona 85258

Patients are needed to participate in a clinical research study evaluating Minnelide™ 001 for the treatment of Advanced Gastrointestinal Tumors

California

Los Angeles California 90095

A clinical research study of ThermoDox for the treatment of Hepatocellular Carcinoma

Sacramento California 95817

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

San Francisco California 94115

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Colorado

Aurora Colorado 80045

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Connecticut

New Haven Connecticut 06519

A clinical trial to evaluate treatments using Sorafenib, Capecitabine for patients with Metastatic Breast Cancer or Gastrointestinal Tumors

New Haven Connecticut 06510-3206

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

District of Columbia

Washington District of Columbia 20006

A clinical trial seeking patients for a research study for the treatment of Colorectal Neoplasms or Colorectal Cancer

Florida

Boca Raton Florida 33486

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Fort Myers Florida 33916

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Gainesville Florida 32610

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Miami Florida 33136

A clinical trial to evaluate treatments for patients with Inflammatory Bowel Disease (IBD), Primary Sclerosing Cholangitis (PSC), Colorectal Neoplasms or Colorectal Cancer

Miami Florida 33136

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Orlando Florida 32804

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

St. Petersburg Florida 33705

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Georgia

Atlanta Georgia 30341

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Atlanta Georgia 30322

Patients are needed to participate in a clinical research study of BBI608, Nab-paclitaxel and Gemcitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Illinois

Arlington Heights Illinois 60005

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Chicago Illinois 60637

A clinical trial to evaluate treatments for patients with Inflammatory Bowel Disease (IBD), Primary Sclerosing Cholangitis (PSC), Colorectal Neoplasms or Colorectal Cancer

Chicago Illinois 60612

A clinical trial to evaluate treatments for patients with Inflammatory Bowel Disease (IBD), Primary Sclerosing Cholangitis (PSC), Colorectal Neoplasms or Colorectal Cancer

Chicago Illinois 60637

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Evanston Illinois 60201

A clinical trial to evaluate treatments for patients with Inflammatory Bowel Disease (IBD), Primary Sclerosing Cholangitis (PSC), Colorectal Neoplasms or Colorectal Cancer

Evanston Illinois 60201

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Indiana

Indianapolis Indiana 46202

Patients are needed to participate in a clinical research study of BBI608, Nab-paclitaxel and Gemcitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Iowa

Iowa City Iowa

A clinical research study of [68Ga]MLN6907 for the treatment of Imaging of Solid Gastrointestinal Tumors

Louisiana

Baton Rouge Louisiana 70809

A clinical trial to evaluate treatments for patients with Inflammatory Bowel Disease (IBD), Primary Sclerosing Cholangitis (PSC), Colorectal Neoplasms or Colorectal Cancer

New Orleans Louisiana 70121

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Maryland

Baltimore Maryland 21205

A Phase 2 clinical study for patients with Metastatic Pancreatic Cancer

Chevy Chase Maryland 20815

A clinical trial seeking patients for a research study for the treatment of Colorectal Neoplasms or Colorectal Cancer

Chevy Chase Maryland 20815

A clinical trial to evaluate treatments for patients with Inflammatory Bowel Disease (IBD), Primary Sclerosing Cholangitis (PSC), Colorectal Neoplasms or Colorectal Cancer

Massachusetts

Boston Massachusetts 02215-5400

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Boston Massachusetts 02215

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Boston Massachusetts 02114

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Michigan

Ann Arbor Michigan 48109

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Detroit Michigan 48201

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Farmington Hills Michigan 48334

A clinical trial to evaluate treatments for patients with Inflammatory Bowel Disease (IBD), Primary Sclerosing Cholangitis (PSC), Colorectal Neoplasms or Colorectal Cancer

Minnesota

Minneapolis Minnesota 55455

Patients are needed to participate in a clinical research study evaluating Minnelide™ 001 for the treatment of Advanced Gastrointestinal Tumors

Rochester Minnesota 55905

A clinical trial to evaluate treatments for patients with Inflammatory Bowel Disease (IBD), Primary Sclerosing Cholangitis (PSC), Colorectal Neoplasms or Colorectal Cancer

Rochester Minnesota 55905

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Missouri

Mexico Missouri 65265

A clinical trial to evaluate treatments for patients with Inflammatory Bowel Disease (IBD), Primary Sclerosing Cholangitis (PSC), Colorectal Neoplasms or Colorectal Cancer

Nebraska

Omaha Nebraska 68114

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

New Jersey

Livingston New Jersey 07039

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

New Mexico

Albuquerque New Mexico

A clinical research study of [68Ga]MLN6907 for the treatment of Imaging of Solid Gastrointestinal Tumors

New York

Buffalo New York 14263

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Lake Success New York 11042

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

New York New York 10065

A clinical research study of TAS-102 and CPT-11 for the treatment of Advanced Gastrointestinal Tumors

New York New York 10029

A clinical trial to evaluate treatments for patients with Inflammatory Bowel Disease (IBD), Primary Sclerosing Cholangitis (PSC), Colorectal Neoplasms or Colorectal Cancer

New York New York 10032

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2